This inventor holds 1 USPTO granted patent. Top assignee: Strand Life Sciences Pvt Ltd.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Innovations by Rajeev Kumar in Organ Toxicity Prediction
Introduction
Rajeev Kumar is an accomplished inventor based in Purnia, India. He has made significant contributions to the field of drug development through his innovative patent. His work focuses on predicting organ toxicity, which is crucial for ensuring the safety and efficacy of new pharmaceuticals.
Latest Patents
Rajeev Kumar holds a patent titled "Method for predicting organ toxicity and a system thereof." This patent presents a systems approach that utilizes mathematical modeling of essential biochemical pathways involved in organ homeostasis. By integrating this in silico model with in-vitro and/or in-vivo measurements, Kumar's method allows for accurate predictions of drug-induced organ injury. The approach also demonstrates the capability to model various physiological situations beyond drug perturbations. Furthermore, it can leverage high-throughput 'omics' data to generate testable hypotheses, facilitating informed decision-making in drug development. He has 1 patent to his name.
Career Highlights
Rajeev Kumar is currently associated with Strand Life Sciences Pvt Ltd, where he continues to advance his research in the field of biotechnology. His work is instrumental in bridging the gap between theoretical models and practical applications in drug safety.
Collaborations
Kumar collaborates with notable colleagues such as Kalyanasundaram Subramanian and Sowmya Raghavan, who contribute to his research endeavors and enhance the impact of his innovations.
Conclusion
Rajeev Kumar's innovative approach to predicting organ toxicity represents a significant advancement in drug development. His contributions are vital for improving the safety of pharmaceuticals and enhancing the understanding of drug interactions within the human body.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile